Rethinking Beneficence in Phase 0 Cancer Clinical Trials

Original language	English
State	Published - 2016
Event	Oxford-Mt. Sinai Consortium on Bioethics - Mt.Sinai, New York, United States Duration: 8 Apr 2016 → 10 Apr 2016

Conference

Conference	Oxford-Mt. Sinai Consortium on Bioethics
Country/Territory	United States
City	Mt.Sinai, New York
Period	8/04/16 → 10/04/16

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Activities

• 1 Invited talk

Activities per year

• Conference Contributed

  Bentwich, M. (Invited speaker)

  8 Apr 2016 → 10 Apr 2016

  Activity: Talk or presentation › Invited talk

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Bentwich, M. (2016). Rethinking Beneficence in Phase 0 Cancer Clinical Trials. Paper presented at Oxford-Mt. Sinai Consortium on Bioethics, Mt.Sinai, New York, United States.

Bentwich, M. / Rethinking Beneficence in Phase 0 Cancer Clinical Trials. Paper presented at Oxford-Mt. Sinai Consortium on Bioethics, Mt.Sinai, New York, United States.

@conference{f38b085b353448438a849cac46bcf0dc,

title = "Rethinking Beneficence in Phase 0 Cancer Clinical Trials",

author = "M. Bentwich",

year = "2016",

language = "אנגלית",

note = "Oxford-Mt. Sinai Consortium on Bioethics ; Conference date: 08-04-2016 Through 10-04-2016",

}

Bentwich, M 2016, 'Rethinking Beneficence in Phase 0 Cancer Clinical Trials', Paper presented at Oxford-Mt. Sinai Consortium on Bioethics, Mt.Sinai, New York, United States, 8/04/16 - 10/04/16.

Rethinking Beneficence in Phase 0 Cancer Clinical Trials. / Bentwich, M.
2016. Paper presented at Oxford-Mt. Sinai Consortium on Bioethics, Mt.Sinai, New York, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Rethinking Beneficence in Phase 0 Cancer Clinical Trials

AU - Bentwich, M.

PY - 2016

Y1 - 2016

M3 - ???researchoutput.researchoutputtypes.contributiontoconference.paper???

T2 - Oxford-Mt. Sinai Consortium on Bioethics

Y2 - 8 April 2016 through 10 April 2016

ER -

Bentwich M. Rethinking Beneficence in Phase 0 Cancer Clinical Trials. 2016. Paper presented at Oxford-Mt. Sinai Consortium on Bioethics, Mt.Sinai, New York, United States.